Location History:
- Kyunggi-do, KR (2002)
- Gyounggi-do, KR (2014)
- Yongin-si, KR (2011 - 2022)
Company Filing History:
6 out of 8 
1 out of 49 
1 out of 548 
Years Active: 2002-2022
Title: The Innovative Contributions of Shin Chung
Introduction
Shin Chung is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, holding a total of 8 patents. His work primarily focuses on developing innovative solutions for medical conditions through advanced genetic techniques.
Latest Patents
Among his latest patents is the invention of HIF 1-alpha antisense oligonucleotides. This invention provides peptide nucleic acid derivatives that target a specific part of the human HIF-1α pre-mRNA. These derivatives are designed to induce exon skipping, resulting in splice variants of HIF-1α mRNA in cells. This technology holds promise for treating conditions associated with the overexpression of HIF-1α. Another significant patent is the SCN9A antisense pain killer, which offers peptide nucleic acid derivatives targeting the 3' splice site of exon 4 in the human SCN9A pre-mRNA. This invention aims to induce splice variants of SCN9A mRNA that lack exon 4, providing a safer treatment option for pain conditions related to Na1.7 activity.
Career Highlights
Shin Chung has worked with several companies throughout his career, including Olipass Corporation and Pacific Corporation. His experience in these organizations has contributed to his innovative research and development efforts in the biotechnology sector.
Collaborations
He has collaborated with notable colleagues such as Heui-Yeon Kim and Hyun-Jin Park, further enhancing the impact of his work in the field.
Conclusion
Shin Chung's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the industry. His innovative approaches to addressing medical challenges continue to pave the way for advancements in treatment options.